OTCPK:SHPHY (Hong Kong)
Â
ADR
$
4.355
(0%)
10:08 PM EST
Business Description
Sihuan Pharmaceutical Holdings Group Ltd
ISIN : US82674Q1058
Share Class Description:
SHPHY: ADRTotal Employee Number:
2,843Compare
Compare
Traded in other countries / regions
00460.Hong KongTEL1.GermanySHPHF.USA IPO Date
2012-09-13Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.95 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 1.2 | |||||
Interest Coverage | 1.86 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.67 | |||||
Beneish M-Score | -2 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.7 | |||||
3-Year FCF Growth Rate | 26.3 | |||||
3-Year Book Growth Rate | 8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 102.53 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 23.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 1.08 | |||||
Days Inventory | 222.94 | |||||
Days Sales Outstanding | 100.34 | |||||
Days Payable | 135.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.28 | |||||
Dividend Payout Ratio | 0.65 | |||||
3-Year Dividend Growth Rate | -11.7 | |||||
Forward Dividend Yield % | 1.28 | |||||
5-Year Yield-on-Cost % | 1.22 | |||||
3-Year Average Share Buyback Ratio | 1 | |||||
Shareholder Yield % | 5.81 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.84 | |||||
Operating Margin % | 14.33 | |||||
Net Margin % | 6.85 | |||||
EBITDA Margin % | 32.24 | |||||
FCF Margin % | -8.25 | |||||
OCF Margin % | -0.84 | |||||
ROE % | 3.72 | |||||
ROA % | 1.66 | |||||
ROIC % | 2.48 | |||||
3-Year ROIIC % | 364.62 | |||||
ROC (Joel Greenblatt) % | 24.43 | |||||
ROCE % | 8.35 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.09 | |||||
PE Ratio without NRI | 50.59 | |||||
Shiller PE Ratio | 52.34 | |||||
PS Ratio | 2.72 | |||||
PB Ratio | 1.2 | |||||
Price-to-Tangible-Book | 1.43 | |||||
EV-to-EBIT | 8.03 | |||||
EV-to-EBITDA | 5.89 | |||||
EV-to-Revenue | 1.9 | |||||
EV-to-FCF | -22.9 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 1.76 | |||||
Price-to-Median-PS-Value | 0.6 | |||||
Price-to-Graham-Number | 1.79 | |||||
| Price-to-Net-Current-Asset-Value | 7.78 | |||||
Earnings Yield (Greenblatt) % | 12.45 | |||||
FCF Yield % | -3.08 | |||||
Forward Rate of Return (Yacktman) % | 17.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SHPHY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sihuan Pharmaceutical Holdings Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 368.597 | ||
| EPS (TTM) ($) | 0.111 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 4.355 - 4.355 | ||
| Shares Outstanding (Mil) | 225.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sihuan Pharmaceutical Holdings Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-28 | In 12 days | ||
| USD 0.055613 Cash Dividend | 2026-07-02 | -- | ||
| General meeting for 2025 | 2026-06-26 10:30 | -- | ||
| Annual report for 2025 | 2026-04-27 | -- | ||
| USD 0.056025 Cash Dividend | 2025-09-29 | -- | ||
| Second quarter earnings results for 2025 | 2025-08-29 | -- | ||
| General meeting for 2024 | 2025-06-06 10:30 | -- | ||
| Annual report for 2024 | 2025-04-28 | -- | ||
| USD 0.108100 Cash Dividend | 2024-09-30 | -- | ||
| Second quarter earnings results for 2024 | 2024-08-30 | -- |
Show
Entries
Sihuan Pharmaceutical Holdings Group Ltd Frequently Asked Questions
What is Sihuan Pharmaceutical Holdings Group Ltd(SHPHY)'s stock price today?
The current price of SHPHY is $4.36. The 52 week high of SHPHY is $4.36 and 52 week low is $4.36.
When is next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(SHPHY)?
The next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(SHPHY) is 2026-08-28 Est..
Does Sihuan Pharmaceutical Holdings Group Ltd(SHPHY) pay dividends? If so, how much?
The Dividend Yield %  of Sihuan Pharmaceutical Holdings Group Ltd(SHPHY) is 1.28% (As of Today), Highest Dividend Payout Ratio of Sihuan Pharmaceutical Holdings Group Ltd(SHPHY) was 0.65. The lowest was 0.11. And the median was 0.35. The  Forward Dividend Yield % of Sihuan Pharmaceutical Holdings Group Ltd(SHPHY) is 1.28%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:SHPHY
No articles.
Press Release
Articles on Sihuan Pharmaceutical Holdings Group Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers